COVID-19 rapid diagnostics: practice review

被引：19

作者：

Reynard, Charles ^{[1
,2
]}

Allen, Joy A. ^{[3
,4
]}

Shinkins, Bethany ^{[5
]}

Prestwich, Graham ^{[6
]}

Goves, Johnathan ^{[2
]}

Davies, Kerrie ^{[7
,8
]}

Body, Richard ^{[1
,2
]}

机构：

[1] Manchester Univ NHS Fdn Trust, Emergency Dept, Manchester, Lancs, England

[2] Univ Manchester, Div Cardiovasc Sci, Manchester, Lancs, England

[3] Newcastle Univ, Sch Clin Med Sci, Translat & Clin Res Inst, NIHR Newcastle Vitro Diagnost Cooperat, Newcastle Upon Tyne, Tyne & Wear, England

[4] Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England

[5] Univ Leeds, Leeds Inst Hlth Sci, Test Evaluat Grp, Leeds, W Yorkshire, England

[6] Yorkshire & Humber Acad Hlth Sci Networks, Patient & Publ Involvement, Leeds, W Yorkshire, England

[7] Univ Leeds, Healthcare Associated Infect Res Grp, Leeds, W Yorkshire, England

[8] Univ Leeds, NIHR Leeds Vitro Diagnost Cooperat, Leeds, W Yorkshire, England

来源：

EMERGENCY MEDICINE JOURNAL | 2022年 / 39卷 / 01期

基金：

英国科研创新办公室;

关键词：

COVID-19; diagnosis; emergency department; infectious diseases;

D O I：

10.1136/emermed-2021-211814

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

Point-of-care tests for SARS-CoV-2 could enable rapid rule-in and/or rule-out of COVID-19, allowing rapid and accurate patient cohorting and potentially reducing the risk of nosocomial transmission. As COVID-19 begins to circulate with other more common respiratory viruses, there is a need for rapid diagnostics to help clinicians test for multiple potential causative organisms simultaneously. However, the different technologies available have strengths and weaknesses that must be understood to ensure that they are used to the benefit of the patient and healthcare system. Device performance is related to the deployed context, and the diagnostic characteristics may be affected by user experience. This practice review is written by members of the UK's COVID-19 National Diagnostic Research and Evaluation programme. We discuss relative merits and test characteristics of various commercially available technologies. We do not advocate for any given test, and our coverage of commercially supplied tests is not intended to be exhaustive.

引用

页码：70 / 76

页数：7

共 42 条

[1] Integrating Early Economic Evaluation into Target Product Profile development for medical tests: advantages and potential applications [J].